glp-1 and estrogen does increase 💡 Did you know medications affect women men differently? While Diabetes: A new insight of

Saxenda (active ingredient: liraglutide) subcutaneous injection Initial FDA Approval: 2014 (liraglutide approved in 2010) Side Effect Update Date: May 28, 2025 Medication Description: For chronic weight management Updated Side Effects/Safety Information: A new warning section on Severe Gastrointestinal Adverse Reactions. An additional warning about the risk of serious kidney injury caused by dehydration due to gastrointestinal adverse effects like diarrhea and vomiting

[PMID: 17563610] PubMed record related to this compound for laboratory literature review

That is not a like-for-like evidence comparison, and the asymmetry itself is the finding

Until safety data exists, avoiding use during these periods is the only prudent approach

Aaseth J, Ellefsen S, Alehagen U, Sundfr TM, Alexander J

This is where GLP-1 medications come in, offering a powerful, science-backed approach